Your browser doesn't support javascript.
loading
CAV1 and KRT5 are potential targets for prostate cancer.
Guo, Liuxiong; Liu, Yixuan; Yang, Tao; Wang, Gang; Liu, Junjiang; Li, Suwei; Liu, Bin; Cai, Jianhui.
Affiliation
  • Guo L; Department of Graduate School, Hebei Medical University, Shijiazhuang, China.
  • Liu Y; Department of Surgery and Urology, Hebei General Hospital, Shijiazhuang, China.
  • Yang T; Department of Rheumatology and Immunology, Hebei General Hospital, Shijiazhuang, China.
  • Wang G; Department of Surgery and Urology, Hebei General Hospital, Shijiazhuang, China.
  • Liu J; Department of Surgery and Urology, Hebei General Hospital, Shijiazhuang, China.
  • Li S; Department of Surgery and Urology, Hebei General Hospital, Shijiazhuang, China.
  • Liu B; YETEM Biotechnology Hebei Corporation, Ltd., Zhengding Area of Hebei Free Trade Zone, Shijiazhuang, China.
  • Cai J; Department of Urology Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang City, Hebei, China.
Medicine (Baltimore) ; 102(49): e36473, 2023 Dec 08.
Article in En | MEDLINE | ID: mdl-38065913
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Caveolin 1 / Keratin-5 / Transforming Growth Factor beta3 Limits: Humans / Male Language: En Journal: Medicine (Baltimore) Year: 2023 Document type: Article Affiliation country: China Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Caveolin 1 / Keratin-5 / Transforming Growth Factor beta3 Limits: Humans / Male Language: En Journal: Medicine (Baltimore) Year: 2023 Document type: Article Affiliation country: China Country of publication: Estados Unidos